Birunthi Niranjan

2.3k total citations
30 papers, 1.4k citations indexed

About

Birunthi Niranjan is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Birunthi Niranjan has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Birunthi Niranjan's work include Prostate Cancer Treatment and Research (13 papers), Cancer Cells and Metastasis (8 papers) and Ferroptosis and cancer prognosis (4 papers). Birunthi Niranjan is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Cancer Cells and Metastasis (8 papers) and Ferroptosis and cancer prognosis (4 papers). Birunthi Niranjan collaborates with scholars based in Australia, United States and United Kingdom. Birunthi Niranjan's co-authors include Gail P. Risbridger, Lakjaya Buluwela, Renea A. Taylor, Ella Evron, David M. Loeb, Sigmund A. Weitzman, Dorian Korz, Tahereh Kamalati, Laki Buluwela and Barry A. Gusterson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biomaterials and Development.

In The Last Decade

Birunthi Niranjan

30 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birunthi Niranjan Australia 16 838 435 326 244 200 30 1.4k
Lakjaya Buluwela United Kingdom 20 935 1.1× 436 1.0× 120 0.4× 276 1.1× 227 1.1× 28 1.6k
Gang Ning United States 13 792 0.9× 210 0.5× 277 0.8× 152 0.6× 301 1.5× 33 1.4k
Masaki Kitazono Japan 22 697 0.8× 659 1.5× 154 0.5× 171 0.7× 233 1.2× 48 1.3k
Tracey Rowlands United States 10 1.0k 1.2× 595 1.4× 115 0.4× 221 0.9× 203 1.0× 14 1.4k
Hio Chung Kang South Korea 26 1.1k 1.3× 654 1.5× 218 0.7× 148 0.6× 312 1.6× 42 1.8k
Sarah Maines‐Bandiera Canada 19 973 1.2× 454 1.0× 115 0.4× 211 0.9× 289 1.4× 23 1.8k
Christopher T. Gubish United States 13 723 0.9× 858 2.0× 683 2.1× 324 1.3× 189 0.9× 17 1.6k
P Wülfing Germany 22 773 0.9× 576 1.3× 191 0.6× 127 0.5× 452 2.3× 47 1.7k
Jari Sundström Finland 22 484 0.6× 520 1.2× 295 0.9× 118 0.5× 332 1.7× 49 1.2k
Eiji Toyoda Japan 18 1.2k 1.4× 788 1.8× 117 0.4× 164 0.7× 320 1.6× 31 1.8k

Countries citing papers authored by Birunthi Niranjan

Since Specialization
Citations

This map shows the geographic impact of Birunthi Niranjan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birunthi Niranjan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birunthi Niranjan more than expected).

Fields of papers citing papers by Birunthi Niranjan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birunthi Niranjan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birunthi Niranjan. The network helps show where Birunthi Niranjan may publish in the future.

Co-authorship network of co-authors of Birunthi Niranjan

This figure shows the co-authorship network connecting the top 25 collaborators of Birunthi Niranjan. A scholar is included among the top collaborators of Birunthi Niranjan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birunthi Niranjan. Birunthi Niranjan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Obinata, Daisuke, Ken‐ichi Takayama, Mitchell G. Lawrence, et al.. (2024). Patient-derived castration-resistant prostate cancer model revealed CTBP2 upregulation mediated by OCT1 and androgen receptor. BMC Cancer. 24(1). 554–554. 4 indexed citations
2.
Keerthikumar, Shivakumar, Susanne Ramm, Daisaku Ashikari, et al.. (2024). Co‐targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor‐null prostate cancer. The Journal of Pathology. 263(2). 242–256. 7 indexed citations
3.
Clark, Kimberley C., Elizabeth V. Nguyen, Birunthi Niranjan, et al.. (2023). Cell-Type-Specific Signalling Networks Impacted by Prostate Epithelial-Stromal Intercellular Communication. Cancers. 15(3). 699–699. 2 indexed citations
4.
Clark, Kimberley C., Birunthi Niranjan, Anderly C. Chüeh, et al.. (2023). Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts. Molecular Oncology. 17(3). 469–486. 7 indexed citations
5.
Souza, David P. De, Birunthi Niranjan, William De Nardo, et al.. (2022). Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer. Molecular Cancer Research. 21(4). 359–373. 6 indexed citations
6.
Papargiris, Melissa, Birunthi Niranjan, Anthony J. Ryan, et al.. (2021). Oxytocin receptor antagonists as a novel pharmacological agent for reducing smooth muscle tone in the human prostate. Scientific Reports. 11(1). 6352–6352. 9 indexed citations
7.
Lawrence, Mitchell G., Ruth Pidsley, Birunthi Niranjan, et al.. (2020). Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer. Clinical Epigenetics. 12(1). 48–48. 22 indexed citations
8.
Nguyen, Elizabeth V., Brooke Pereira, Mitchell G. Lawrence, et al.. (2019). Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment. Molecular & Cellular Proteomics. 18(7). 1410–1427. 77 indexed citations
9.
10.
Lee, Rachel S., Luxi Zhang, Adeline Berger, et al.. (2019). Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target. Neoplasia. 21(4). 389–400. 24 indexed citations
11.
Niranjan, Birunthi, et al.. (2014). Preliminary investigations into triazole derived androgen receptor antagonists. Bioorganic & Medicinal Chemistry. 22(9). 2692–2706. 15 indexed citations
12.
Lawrence, Mitchell G., Renea A. Taylor, Roxanne Toivanen, et al.. (2013). A preclinical xenograft model of prostate cancer using human tumors. Nature Protocols. 8(5). 836–848. 75 indexed citations
13.
Niranjan, Birunthi, Mitchell G. Lawrence, Melissa Papargiris, et al.. (2012). Primary Culture and Propagation of Human Prostate Epithelial Cells. Methods in molecular biology. 945. 365–382. 13 indexed citations
14.
Henderson, Luke C., et al.. (2011). A comparative assessment of α-lipoic acid N-phenylamides as non-steroidal androgen receptor antagonists both on and off gold nanoparticles. Bioorganic Chemistry. 40(1). 1–5. 15 indexed citations
15.
McPherson, Stephen J., Preetika Balanathan, Shelley Hedwards, et al.. (2010). Estrogen receptor–β activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFα mediated. Proceedings of the National Academy of Sciences. 107(7). 3123–3128. 168 indexed citations
17.
Gold, Elspeth, Moira K. O’Bryan, Sarah J. Meachem, et al.. (2008). Activin C Antagonizes Activin A in Vitro and Overexpression Leads to Pathologies in Vivo. American Journal Of Pathology. 174(1). 184–195. 60 indexed citations
18.
Kamalati, Tahereh, et al.. (1999). HGF/SF in Mammary Epithelial Growth and Morphogenesis: In Vitro and In Vivo Models. Journal of Mammary Gland Biology and Neoplasia. 4(1). 69–77. 28 indexed citations
19.
Buluwela, Lakjaya, et al.. (1998). In VivoEffects of Hepatocyte Growth Factor/Scatter Factor on Mouse Mammary Gland Development. Experimental Cell Research. 241(2). 476–481. 41 indexed citations
20.
Kamalati, Tahereh, et al.. (1996). Differentiation antigens in stromal and epithelial cells of the breast. Cancer treatment and research. 83. 227–242. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026